[시장보고서]세계의 생명과학 IT 시장 규모 조사 : 솔루션별, 유형별, 최종사용자별, 지역별 전망(2022-2032년)

세계의 생명과학 IT 시장 규모 조사 : 솔루션별, 유형별, 최종사용자별, 지역별 전망(2022-2032년)

Global Life Sciences IT Market Size Study, by Solution, by Type, by End User and Regional Forecasts 2022-2032

상품코드 : 1514876

리서치사 : Bizwit Research & Consulting LLP

발행일 : 2024년 07월

페이지 정보 : 영문 200 Pages

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계 생명과학 IT 시장은 2023년 약 214억 1,000만 달러로 평가되었고, 2024년부터 2032년까지 12.11% 이상의 견조한 성장률을 보일 것으로 예측됩니다.

생명과학 IT 솔루션은 생명과학 분야에서 복잡한 생물학적 데이터를 관리, 분석 및 해석하는 데 매우 중요합니다. 이러한 정교한 도구는 연구, 신약 개발, 임상시험, 의료 관리 등 다양한 프로세스를 간소화합니다. 생명과학 IT 소프트웨어는 데이터 관리, 분석, 시각화를 위한 용도를 포괄하여 복잡한 생물학적 및 임상 데이터의 수집, 저장, 해석을 용이하게 합니다. 생명과학 IT 솔루션은 연구자들이 실험을 수행하고 결과를 분석하여 신약개발, 유전체, 단백질체학, 맞춤의료 등의 분야에서 정보에 입각한 의사결정을 내릴 수 있도록 지원함으로써 과학 연구와 의료 서비스 제공의 발전에 크게 기여하고 있습니다.

세계 생명과학 IT 시장은 생명과학 분석 소프트웨어의 채택 증가와 만성질환의 확산으로 인해 질병 진단의 정확성을 높이는 첨단 영상진단 및 진단 소프트웨어에 대한 수요가 증가하고 있습니다. 의료 서비스 제공업체들은 분석 소프트웨어를 활용하여 업무 효율성을 최적화하고, 집단 건강을 관리하며, 의료 비용을 절감하고 있습니다. 환자 데이터와 치료 결과를 분석함으로써 의료 서비스 제공업체는 근거에 기반한 의사결정을 내리고 임상 결과와 자원 활용을 개선할 수 있습니다. 또한, 인공지능(AI) 및 머신러닝(ML)과 같은 첨단 계산 도구를 생명과학 IT 플랫폼에 통합함으로써 신약 개발 절차가 바뀌고 있으며, AI 알고리즘은 약물 표적의 신속한 스크리닝 및 우선순위 결정, 분자 간 상호작용 예측, 생물학적 과정의 생물학적 과정의 시뮬레이션을 전례 없는 정밀도와 정확도로 수행할 수 있습니다. 또한, 인공지능과 머신러닝의 통합, 고급 계산 도구의 통합과 같은 기술 발전은 시장 확대에 큰 기회를 제공할 것으로 예상됩니다. 그러나 데이터 프라이버시 및 보안에 대한 우려는 생명과학 IT 시장에 큰 도전을 가져와 잠재적 성장에 영향을 미치고 있습니다.

세계의 생명과학 IT 시장 조사에서 고려된 주요 지역은 아시아태평양, 북미, 유럽, 중남미, 기타 유럽으로, 2023년 북미는 지역 전체 의료비 지출 증가 등의 요인으로 인해 지역 시장 내에서 압도적인 수익성을 보였습니다. 이 지역의 막대한 의료비 지출은 환자 치료 개선, 운영 효율성 향상, 의료 비용 절감을 위한 IT 솔루션에 대한 투자를 뒷받침하고 있습니다. 정밀의료, 유전체 의학, 개인 맞춤형 의료 등의 분야에서 IT 혁신은 환자 예후를 개선하고 의료 서비스 제공에 기여하고 있습니다. 또한, 아시아태평양 시장은 2024년부터 2032년까지 가장 빠른 속도로 성장할 것으로 예측됩니다.

조사 목적
시장 정의
조사의 전제조건
- 포함과 제외
- 제한 사항
- 공급측 분석
  - 가용성
  - 인프라
  - 규제 환경
  - 시장 경쟁
  - 경제성(소비자 시점)
- 수요측 분석
  - 규제 프레임워크
  - 기술 진보
  - 친환경
  - 소비자 의식과 수용
조사 방법
조사 대상년도
통화 환산율

제3장 세계의 생명과학 IT 시장 역학

시장 성장 촉진요인 ]
시장이 해결해야 할 과제
시장 기회

영문 목차

영문목차

Global Life Sciences IT Market is valued at approximately USD 21.41 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.11% over the forecast period 2024-2032. Life science IT solutions are pivotal in managing, analyzing, and interpreting complex biological data within the life sciences domain. These sophisticated tools streamline various processes, including research, drug discovery, clinical trials, and healthcare management. Life science IT software encompasses applications for data management, analysis, and visualization, facilitating the collection, storage, and interpretation of complex biological and clinical data. By enabling researchers to conduct experiments, analyze results, and make informed decisions in areas such as drug discovery, genomics, proteomics, and personalized medicine, life science IT solutions significantly contribute to advancing scientific research and healthcare delivery.

The Global Life Sciences IT Market is driven by rising adoption of life science analytics software growing prevalence of chronic diseases fuel the demand for advanced imaging and diagnostic software that enhances disease diagnosis accuracy. Healthcare providers utilize analytics software to optimize operational efficiency, manage population health, and reduce healthcare costs. Through analyzing patient data and treatment outcomes, providers can make evidence-based decisions that enhance clinical outcomes and resource utilization. In addition, integration of advanced computational tools, such as artificial intelligence (AI) and machine learning (ML), within life science IT platforms has revolutionized drug discovery procedures. AI algorithms can rapidly screen and prioritize drug targets, predict molecular interactions, and simulate biological processes with unprecedented precision and accuracy. Moreover, technological advancements, such as the integration of artificial intelligence and machine learning, and integration of advanced computational tools are expected to provide significant opportunities for market expansion. However, data privacy and security concerns pose significant challenges to the life sciences IT market, impacting its potential growth.

The key regions considered for the Global Life Sciences IT Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the dominating among regional market in terms of revenue owing to factors such as increasing healthcare expenditure across the region. The region's substantial healthcare expenditure supports investments in IT solutions aimed at improving patient care, enhancing operational efficiency, and reducing healthcare costs. IT innovations in areas such as precision medicine, genomics, and personalized healthcare contribute to better patient outcomes and healthcare delivery. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:

Qiagen NV
Oracle Corporation
Genedata AG
IBM Corporation
Illumina, Inc.
Agilent Technologies, Inc.
DNAnexus, Inc.
Revvity, Inc.
Clario
Thermo Fisher Scientific Inc.

The detailed segments and sub-segment of the market are explained below:

By Solution

Drug Discovery Informatics
Clinical Trial Management
Bioinformatics
Laboratory Information Management
Others

By Type

Software
Service

By End User

Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Life Sciences IT Market Executive Summary

1.1. Global Life Sciences IT Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Solution
- 1.3.2. By Type
- 1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Life Sciences IT Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Life Sciences IT Market Dynamics

3.1. Market Drivers
- 3.1.1. Rise in Adoption of Life Science Analytics Software
- 3.1.2. Increase in Chronic Diseases and Demand for Advanced Imaging
- 3.1.3. Growth in Laboratory Automation
3.2. Market Challenges
- 3.2.1. Data Privacy and Security Concerns
3.3. Market Opportunities
- 3.3.1. Technological Advancements in AI and ML
- 3.3.2. Expansion in Emerging Markets
- 3.3.3. Integration of Advanced Computational Tools

Chapter 4. Global Life Sciences IT Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Life Sciences IT Market Size & Forecasts by Solution 2022-2032

5.1. Segment Dashboard
5.2. Global Life Sciences IT Market: Solution Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Drug Discovery Informatics
- 5.2.2. Clinical Trial Management
- 5.2.3. Bioinformatics
- 5.2.4. Laboratory Information Management
- 5.2.5. Others

Chapter 6. Global Life Sciences IT Market Size & Forecasts by Type 2022-2032

6.1. Segment Dashboard
6.2. Global Life Sciences IT Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Software
- 6.2.2. Services

Chapter 7. Global Life Sciences IT Market Size & Forecasts by End User 2022-2032

7.1. Segment Dashboard
7.2. Global Life Sciences IT Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Pharmaceutical and Biotechnology Companies
- 7.2.2. Contract Research and Development Organizations
- 7.2.3. Others

Chapter 8. Global Life Sciences IT Market Size & Forecasts by Region 2022-2032

8.1. North America Life Sciences IT Market
- 8.1.1. U.S. Life Sciences IT Market
  - 8.1.1.1. Solution breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Type breakdown size & forecasts, 2022-2032
  - 8.1.1.3. End User breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Life Sciences IT Market
  - 8.1.2.1. Solution breakdown size & forecasts, 2022-2032
  - 8.1.2.2. Type breakdown size & forecasts, 2022-2032
  - 8.1.2.3. End User breakdown size & forecasts, 2022-2032
8.2. Europe Life Sciences IT Market
- 8.2.1. U.K. Life Sciences IT Market
  - 8.2.1.1. Solution breakdown size & forecasts, 2022-2032
  - 8.2.1.2. Type breakdown size & forecasts, 2022-2032
  - 8.2.1.3. End User breakdown size & forecasts, 2022-2032
- 8.2.2. Germany Life Sciences IT Market
  - 8.2.2.1. Solution breakdown size & forecasts, 2022-2032
  - 8.2.2.2. Type breakdown size & forecasts, 2022-2032
  - 8.2.2.3. End User breakdown size & forecasts, 2022-2032
- 8.2.3. France Life Sciences IT Market
  - 8.2.3.1. Solution breakdown size & forecasts, 2022-2032
  - 8.2.3.2. Type breakdown size & forecasts, 2022-2032
  - 8.2.3.3. End User breakdown size & forecasts, 2022-2032
- 8.2.4. Spain Life Sciences IT Market
  - 8.2.4.1. Solution breakdown size & forecasts, 2022-2032
  - 8.2.4.2. Type breakdown size & forecasts, 2022-2032
  - 8.2.4.3. End User breakdown size & forecasts, 2022-2032
- 8.2.5. Italy Life Sciences IT Market
  - 8.2.5.1. Solution breakdown size & forecasts, 2022-2032
  - 8.2.5.2. Type breakdown size & forecasts, 2022-2032
  - 8.2.5.3. End User breakdown size & forecasts, 2022-2032
- 8.2.6. Rest of Europe Life Sciences IT Market
  - 8.2.6.1. Solution breakdown size & forecasts, 2022-2032
  - 8.2.6.2. Type breakdown size & forecasts, 2022-2032
  - 8.2.6.3. End User breakdown size & forecasts, 2022-2032
8.3. Asia-Pacific Life Sciences IT Market
- 8.3.1. China Life Sciences IT Market
  - 8.3.1.1. Solution breakdown size & forecasts, 2022-2032
  - 8.3.1.2. Type breakdown size & forecasts, 2022-2032
  - 8.3.1.3. End User breakdown size & forecasts, 2022-2032
- 8.3.2. India Life Sciences IT Market
  - 8.3.2.1. Solution breakdown size & forecasts, 2022-2032
  - 8.3.2.2. Type breakdown size & forecasts, 2022-2032
  - 8.3.2.3. End User breakdown size & forecasts, 2022-2032
- 8.3.3. Japan Life Sciences IT Market
  - 8.3.3.1. Solution breakdown size & forecasts, 2022-2032
  - 8.3.3.2. Type breakdown size & forecasts, 2022-2032
  - 8.3.3.3. End User breakdown size & forecasts, 2022-2032
- 8.3.4. Australia Life Sciences IT Market
  - 8.3.4.1. Solution breakdown size & forecasts, 2022-2032
  - 8.3.4.2. Type breakdown size & forecasts, 2022-2032
  - 8.3.4.3. End User breakdown size & forecasts, 2022-2032
- 8.3.5. South Korea Life Sciences IT Market
  - 8.3.5.1. Solution breakdown size & forecasts, 2022-2032
  - 8.3.5.2. Type breakdown size & forecasts, 2022-2032
  - 8.3.5.3. End User breakdown size & forecasts, 2022-2032
- 8.3.6. Rest of Asia Pacific Life Sciences IT Market
  - 8.3.6.1. Solution breakdown size & forecasts, 2022-2032
  - 8.3.6.2. Type breakdown size & forecasts, 2022-2032
  - 8.3.6.3. End User breakdown size & forecasts, 2022-2032
8.4. Latin America Life Sciences IT Market
- 8.4.1. Brazil Life Sciences IT Market
  - 8.4.1.1. Solution breakdown size & forecasts, 2022-2032
  - 8.4.1.2. Type breakdown size & forecasts, 2022-2032
  - 8.4.1.3. End User breakdown size & forecasts, 2022-2032
- 8.4.2. Mexico Life Sciences IT Market
  - 8.4.2.1. Solution breakdown size & forecasts, 2022-2032
  - 8.4.2.2. Type breakdown size & forecasts, 2022-2032
  - 8.4.2.3. End User breakdown size & forecasts, 2022-2032
- 8.4.3. Rest of Latin America Life Sciences IT Market
  - 8.4.3.1. Solution breakdown size & forecasts, 2022-2032
  - 8.4.3.2. Type breakdown size & forecasts, 2022-2032
  - 8.4.3.3. End User breakdown size & forecasts, 2022-2032
8.5. Middle East & Africa Life Sciences IT Market
- 8.5.1. Saudi Arabia Life Sciences IT Market
  - 8.5.1.1. Solution breakdown size & forecasts, 2022-2032
  - 8.5.1.2. Type breakdown size & forecasts, 2022-2032
  - 8.5.1.3. End User breakdown size & forecasts, 2022-2032
- 8.5.2. South Africa Life Sciences IT Market
  - 8.5.2.1. Solution breakdown size & forecasts, 2022-2032
  - 8.5.2.2. Type breakdown size & forecasts, 2022-2032
  - 8.5.2.3. End User breakdown size & forecasts, 2022-2032
- 8.5.3. Rest of Middle East & Africa Life Sciences IT Market
  - 8.5.3.1. Solution breakdown size & forecasts, 2022-2032
  - 8.5.3.2. Type breakdown size & forecasts, 2022-2032
  - 8.5.3.3. End User breakdown size & forecasts, 2022-2032

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Qiagen NV
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Oracle Corporation
- 9.3.3. Genedata AG
- 9.3.4. IBM Corporation
- 9.3.5. Illumina, Inc.
- 9.3.6. Agilent Technologies, Inc.
- 9.3.7. DNAnexus, Inc.
- 9.3.8. Revvity, Inc.
- 9.3.9. Clario
- 9.3.10. Thermo Fisher Scientific Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes

한글목차

목차

제1장 세계의 생명과학 IT 시장 주요 요약

제2장 세계의 생명과학 IT 시장 정의와 조사의 전제조건